Premium
Improvement in Conditions for Solubilisation and Characterisation of Brain D 2 Dopamine Receptors Using Various Detergents
Author(s) -
Wheatley Mark,
Hall Jean M.,
Frankham Patricia A.,
Strange Philip G.
Publication year - 1984
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.1984.tb12826.x
Subject(s) - spiperone , chaps , chemistry , receptor , dopamine receptor , dopamine , chromatography , biochemistry , binding site , enzyme , biology , neuroscience
Abstract: A series of detergents of varying chemical properties has been tested for solubilisation of bovine caudate nucleus D 2 dopamine receptors using [ 3 H]spiperone binding to assay the solubilised sites. The properties of the lysophosphatidylcholine (LPC)‐ and 3‐[(3‐cholamidopropyl)dimethylammonio]‐1‐propane‐sulphonate (CHAPS)‐solubilised preparations are described in detail. The preparations are truly solubilised, and sucrose density gradient and gel filtration data are reported. Specific [ 3 H]spiperone binding in the LPC‐solubilised preparation assayed at 4°C is solely to D 2 dopamine re‐ceptors. If the assay temperature is raised to 25°C, the amount of specific [ 3 H]spiperone binding is largely unchanged, but it forms a greater proportion of the total [ 3 H]spiperone binding owing to a reduction in nonstereospecific (spirodecanone) [ 3 H]spiperone binding at the higher temperature. The effect of raising the assay temperature is important as it enables more precise deter‐minations of specific [ 3 H]spiperone binding to be made. Part of the specific [ 3 H]spiperone binding at 25°C is to solubilised S 2 serotonin receptors in addition to D 2 dopamine receptors. Good correlations are observed between the affinities for binding of ligands to the solubilised D 2 receptors and corresponding data obtained on membrane‐bound receptors. Agonist binding in LPC‐solubilised preparations is insensitive to guanine nucleotides. It is speculated that the spirodecanone sites represent, in part, proteolysed or damaged D 2 dopamine, or S 2 serotonin, receptors. In the CHAPS‐solubilised preparation the pharmacological profile of [ 3 H]spiperone binding is unclear when assayed at 4°C, but in assays at 25°C a clear serotonin S 2 receptor component of specific [ 3 H]spiperone binding can be discerned. No clear D 2 dopamine receptor component can be detected in this preparation under these conditions.